Generic Drugs
7 articles on Generic Drugs, written by Shotlee and medically reviewed for clinical accuracy.
Generic Ozempic® Now Available in Canada: What You Need to Know
Apotex Inc. has launched Apo-Semaglutide Injection™, a generic version of Ozempic®, in Canada. This development brings a more affordable treatment option for type 2 diabetes management to Canadian patients and healthcare providers.
6 min read
Generic Ozempic Semaglutide Gets Tentative USFDA Approval; OneSource CDMO Par...
A generic version of Ozempic semaglutide has received tentative USFDA approval, marking a key step toward affordable GLP-1 therapy. Orbicular spearheaded product development, partnering with OneSource Specialty Pharma as the CDMO for reliable U.S. market manufacturing. This collaboration promises steady commercial supply from an FDA-approved site.
5 min read
Semaglutide Could Cost as Little as $28/Year by End of 2026
Semaglutide, the powerhouse behind Ozempic and Wegovy, might soon become dramatically more affordable. A recent study reveals generic versions could cost as little as $28 per person-year after patents expire in 2026. This could transform access to treatment for obesity and type 2 diabetes globally.
5 min read
Ozempic-Like Drugs in India May Drop 50% in Price from March 2026
Semaglutide-based weight-loss drugs like Ozempic and Wegovy are set for a price revolution in India, with generics launching after patent expiry on March 20, 2026, potentially halving costs. Domestic giants like Sun Pharmaceutical and Dr. Reddy's are gearing up to make these GLP-1 therapies more affordable amid rising obesity rates. This shift could transform access to effective treatments for diabetes and weight management.
5 min read
Dr Reddy's Wegovy Generic Set for 50-60% Discounts in India
Indian drugmaker Dr Reddy's Laboratories is gearing up to launch a generic version of Novo Nordisk's Wegovy at prices up to 60% lower than the original. Co-chairman G V Prasad confirmed 50-60% discounts are feasible as semaglutide's patent nears expiry in March. This could reshape access to weight-loss treatments in India's competitive market.
5 min read
Firms Will Be Able to Produce Generic Ozempic Starting Next Week, Yet Availability Remains Distant
Health Canada acknowledges public demand for cheaper generic options for the popular drug Ozempic. Several companies have filed for authorization, though timelines are unclear. Patients may face delays in accessing these alternatives.
1 min read
Dr. Reddy's Cleared by Delhi HC to Export Semaglutide Generics of Novo Nordisk
An Indian court has granted Dr. Reddy's Laboratories Ltd permission to manufacture and export generic versions of Novo Nordisk's diabetes and obesity medications. This decision comes before the global patent expirations in 2026. The ruling allows export to countries without patent protection.
2 min read